Safety and efficacy of a single intra-articular injection of a novel enhanced protein solution (JTA-004) compared to hylan G-F 20 in symptomatic knee osteoarthritis: a randomized, double-blind, controlled phase II/III study

一项随机、双盲、对照的II/III期研究：比较单次关节内注射新型增强型蛋白溶液（JTA-004）与透明质酸生长因子20（hylan GF 20）治疗症状性膝骨关节炎的安全性和有效性。